Pharmaceutical Combinations

Patent No. EP3463345 (titled "Pharmaceutical Combinations") was filed by Array Biopharma on Jun 2, 2017. The application was issued on Nov 2, 2022.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
KRAUS & LEDERER PARTGMBB	Aug 1, 2023	KRAUS & LEDERER PARTGMBB
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB	Aug 1, 2023	TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Mar 25, 2024
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Mar 25, 2024
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Mar 25, 2024
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Mar 13, 2024
Letter accompanying subsequently filed items
Jan 24, 2024
Brief communication - Opposition proceedings
Jan 24, 2024
Brief communication - Opposition proceedings
Jan 24, 2024
Communication of amended entries
Jan 15, 2024
Advice of delivery
Dec 21, 2023
(Electronic) Receipt
Dec 21, 2023
Advice of delivery
Dec 21, 2023
Letter accompanying subsequently filed items
Dec 19, 2023
Decision revoking the European patent
Dec 19, 2023
Decision revoking the European patent
Dec 19, 2023
Decision revoking the European patent
Dec 19, 2023
Transmittal of decision / summons - opposition
Dec 19, 2023
Transmittal of decision / summons - opposition
Dec 19, 2023
Transmittal of decision / summons - opposition
Dec 13, 2023
(Electronic) Receipt
Dec 13, 2023
Letter accompanying subsequently filed items
Dec 13, 2023
Request for revocation of patent
Dec 12, 2023
Letter accompanying subsequently filed items
Dec 12, 2023
Letter accompanying subsequently filed items
Dec 12, 2023
Request for change of name -opponent
Dec 12, 2023
Request for change of opponent's representative
Aug 17, 2023
Communication of a notice of opposition and request to file observations
Aug 17, 2023
Notice of further oppositions to opponent(s)
Aug 17, 2023
Notice of further oppositions to opponent(s)
Aug 7, 2023
Communication of a notice of opposition - first information to patent proprietor
Aug 4, 2023
Communication of a notice of opposition - first information to patent proprietor
Aug 1, 2023
(Electronic) Receipt
Aug 1, 2023
(Electronic) Receipt
Aug 1, 2023
Citation in opposition procedure
Aug 1, 2023
Citation in opposition procedure - 001
Aug 1, 2023
Citation in opposition procedure - 002
Aug 1, 2023
Citation in opposition procedure - 003
Aug 1, 2023
Citation in opposition procedure - 004
Aug 1, 2023
Citation in opposition procedure - 005
Aug 1, 2023
Citation in opposition procedure - 006
Aug 1, 2023
Citation in opposition procedure - 007
Aug 1, 2023
Citation in opposition procedure - 008
Aug 1, 2023
Citation in opposition procedure - 009
Aug 1, 2023
Citation in opposition procedure - 010
Aug 1, 2023
Citation in opposition procedure - 011
Aug 1, 2023
Citation in opposition procedure - 012
Aug 1, 2023
Citation in opposition procedure - 013
Aug 1, 2023
Citation in opposition procedure - 014
Aug 1, 2023
Citation in opposition procedure - 015
Aug 1, 2023
Citation in opposition procedure - 016
Aug 1, 2023
Citation in opposition procedure - 017
Aug 1, 2023
Citation in opposition procedure - 018
Aug 1, 2023
Citation in opposition procedure - 019
Aug 1, 2023
Citation in opposition procedure - 020
Aug 1, 2023
Consolidated list of cited opposition documents
Aug 1, 2023
Notice of opposition
Aug 1, 2023
Notice of opposition
Aug 1, 2023
Notice of opposition
Aug 1, 2023
Notice of opposition
Nov 15, 2022
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Oct 7, 2022
Decision to grant a European patent
Sep 12, 2022
(Electronic) Receipt
Sep 12, 2022
French translation of claims
Sep 12, 2022
German translation of the claims
Sep 12, 2022
Letter accompanying subsequently filed items
Jun 8, 2022
Bibliographic data of the European patent application
Jun 8, 2022
Communication about intention to grant a European patent
Jun 8, 2022
Intention to grant (signatures)
Jun 8, 2022
Text intended for grant (clean copy)
Jun 8, 2022
Text intended for grant (version for approval)
Feb 12, 2021
(Electronic) Receipt
Feb 12, 2021
Amended claims with annotations
Feb 12, 2021
Amended description with annotations
Feb 12, 2021
Claims
Feb 12, 2021
Description
Feb 12, 2021
Letter accompanying subsequently filed items
Feb 12, 2021
Reply to communication from the Examining Division
Dec 4, 2020
Annex to the communication
Dec 4, 2020
Communication from the Examining Division
Nov 26, 2020
Examination started
Jun 26, 2020
(Electronic) Receipt
Jun 26, 2020
Letter accompanying subsequently filed items
Jun 26, 2020
Non-patent literature cited during the examination procedure
Jun 26, 2020
Non-patent literature cited during the examination procedure
Jun 26, 2020
Reply to Written Opinion prepared by the EPO
Feb 11, 2020
Invitation to declare maintenance of the application and to correct deficiencies in the Written Opinion/amend application
Jan 23, 2020
Communication regarding the transmission of the European search report
Jan 23, 2020
European search opinion
Jan 23, 2020
Information on Search Strategy
Jan 23, 2020
Supplementary European search report
Jan 22, 2020
Communication of the registration of a transfer or change of name and/or address
Jan 15, 2020
(Electronic) Receipt
Jan 15, 2020
Annexes in respect of a client data request
Jan 15, 2020
Letter accompanying subsequently filed items
Jan 15, 2020
Submission concerning a transfer of rights (applicant)
Dec 11, 2019
Search started
Dec 4, 2019
Indication of deficiencies in a request for registering a transfer of rights and invitation to correct them
Nov 28, 2019
Important information concerning EPO Form 1010
Nov 14, 2019
(Electronic) Receipt
Nov 14, 2019
Annexes in respect of a client data request
Nov 14, 2019
Annexes in respect of a client data request
Nov 14, 2019
Annexes in respect of a client data request
Nov 14, 2019
Annexes in respect of a client data request
Nov 14, 2019
Annexes in respect of a client data request
Nov 14, 2019
Annexes in respect of a client data request
Nov 14, 2019
Annexes in respect of a client data request
Nov 14, 2019
Letter accompanying subsequently filed items
Nov 14, 2019
Submission concerning a transfer of rights (applicant)
Mar 13, 2019
Notification on forthcoming publication of bibliographic data
Jan 23, 2019
Communication regarding possible amendment of the application/payment of claims fee
Dec 20, 2018
(Electronic) Receipt
Dec 20, 2018
Amended claims filed after receipt of (European) search report
Dec 20, 2018
Amendments received before examination
Dec 20, 2018
Copy of the international preliminary report on patentability
Dec 20, 2018
Request for entry into the European phase
Oct 12, 2018
Information on entry into European phase
Feb 20, 2018
Priority document (electronically transmitted)
Dec 7, 2017
Copy of the international search report
Dec 7, 2017
Published international application - A1

EP3463345

ARRAY BIOPHARMA

Application Number: EP17807555A
Filing Date: Jun 2, 2017
Status: Revoked; Mar 22, 2024
Publication Date: Nov 2, 2022
External Links: Slate, Register , Google Patents

IP Verse

Pharmaceutical Combinations

Patent Summary

Patent Family

Patent Oppositions (2)

Dossier Documents

EP3463345